Performance of 4 Methods to Assess Health-Related Social Needs
In this cross-sectional study of HRSN measurement, no approach performed strongly for every HRSN, and every approach had indication of unfair performance. These findings suggest that practitioners, health care and public health organizations, researchers, and policymakers who rely on a single method to collect HRSN data will likely underestimate patients' true social burden.
Authors
- Christopher A. Harle (ORCID: https://orcid.org/0000-0002-4803-3632)
- Eneida A. Mendonça (ORCID: https://orcid.org/0000-0003-4297-9221)
- Joshua R. Vest (ORCID: https://orcid.org/0000-0002-7226-9688)
- Megan E. Gregory (ORCID: https://orcid.org/0000-0002-6888-6886)
- Tanja Magoč (ORCID: https://orcid.org/0000-0001-8213-2266)
- Cassidy McNamee (ORCID: https://orcid.org/0009-0006-4991-0613)
- Shaun J. Grannis (ORCID: https://orcid.org/0000-0002-8093-6639)
- Suranga Kasturi (ORCID: https://orcid.org/0000-0002-6630-4598)
- Wei Wu (ORCID: https://orcid.org/0000-0001-7955-461X)
- Jiang Bian (ORCID: https://orcid.org/0000-0002-9034-4960)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Regenstrief Institute (US)
- University of Florida Health (US)
- Richard M. Fairbanks Foundation (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.27426
- Citations
- 1
- Primary Topic
- Food Security and Health in Diverse Populations
- Type
- article
- Field-Weighted Citation Impact
- 2.82
Funders
- Eli Lilly and Company
- Pfizer
- Lilly Endowment
- Agency for Healthcare Research and Quality